14Jul
Japan Tightens Foreign Direct Investment Regulations on Life Science Companies - Prior notification requirements under the Japanese regulations were expanded to cover investments in life science companies.
On June 15, 2020, the Japanese government implemented new regulations that designate the manufacture of pharmaceuticals for infectious diseases and the manufacture of highly-controlled medical devices (medical devices that are classified as Class III or Class IV in Japan, such as a heart–lung machines and ventilators) as both "Designated Businesses" and "Core Businesses" under the Foreign Exchange and Foreign Trade Act of Japan ("FEFTA"). The new regulations were adopted in light of the COVID-19...
By:
Jones Day
Related
The novel coronavirus outbreak was first alerted to the World Health Organisation (WHO) by Chinese a...
Read More >
Please take note that the Florida Building Commission has adopted the Seventh Edition of the Florida...
Read More >
The Boston Globe has a well-reported story out this morning on the United Food and Commercial Worker...
Read More >
In the midst of the ongoing COVID-19 public health emergency, New Jersey-based builders, developers,...
Read More >
The Americans with Disabilities Act (ADA) does not protect employees from discrimination based on po...
Read More >
As Arizona employers prepare for 2020, key minimum wages and exempt salary levels under city, state,...
Read More >